Literature DB >> 15912324

[Molecular biology approach to explain lymphatic metastasis].

F Vom Dorp1, B Wullich, E Gulbins, A Eisenhardt.   

Abstract

The spread of tumor cells of solid tumors to the regional lymph nodes is an important step in the progression of the disease and also an important prognostic factor. While the significance of the prognostic value of the lymphatic progression had been detected long ago, only increased knowledge of the molecular anatomy and mechanisms involved in the lymphatic spread of tumor cells provided a beginning insight into the understanding of lymphatic metastasis. One group of important molecular factors consists of proteins produced by the tumor cells inducing a proliferation of lymphatic vessels into the primary tumor. The vascular endothelial growth factors have been identified as key factors in this process. In addition there are hints for the fact that chemokines, which are cytokine-like proteins taking part in the regulation of processes of inflammation, and their chemokine receptors control cellular key steps of lymphatic metastasis of tumor cells such as migration, proliferation, and invasion. In conclusion new data point to the possible inhibition of lymphatic spread by selective blockade of growth factor receptors or chemokine receptors. The growing insight into cellular understanding of the mechanisms involved in the metastasis of tumor cells into the lymphatics and lymph nodes will hopefully facilitate the development of new diagnostic and therapeutic tools in the treatment of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912324     DOI: 10.1007/s00120-005-0833-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  50 in total

Review 1.  LYVE-1, the lymphatic system and tumor lymphangiogenesis.

Authors:  D G Jackson; R Prevo; S Clasper; S Banerji
Journal:  Trends Immunol       Date:  2001-06       Impact factor: 16.687

2.  VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues.

Authors:  T A Partanen; J Arola; A Saaristo; L Jussila; A Ora; M Miettinen; S A Stacker; M G Achen; K Alitalo
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

Review 3.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.

Authors:  Shahin Rafii; David Lyden
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

4.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

Authors:  G A Donzella; D Schols; S W Lin; J A Esté; K A Nagashima; P J Maddon; G P Allaway; T P Sakmar; G Henson; E De Clercq; J P Moore
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

5.  LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.

Authors:  C Mouta Carreira; S M Nasser; E di Tomaso; T P Padera; Y Boucher; S I Tomarev; R K Jain
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 6.  Chemokines: agents for the immunotherapy of cancer?

Authors:  Bernhard Homey; Anja Müller; Albert Zlotnik
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

7.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.

Authors:  H E Wiley; E B Gonzalez; W Maki; M T Wu; S T Hwang
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

8.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Authors:  T Asahara; H Masuda; T Takahashi; C Kalka; C Pastore; M Silver; M Kearne; M Magner; J M Isner
Journal:  Circ Res       Date:  1999-08-06       Impact factor: 17.367

9.  Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.

Authors:  M G Achen; S Roufail; T Domagala; B Catimel; E C Nice; D M Geleick; R Murphy; A M Scott; C Caesar; T Makinen; K Alitalo; S A Stacker
Journal:  Eur J Biochem       Date:  2000-05

10.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.